Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Healthcare Industry News How Organigram Global hopes new CEO James Yamanaka will accelerate brand and export strategy Organigram Global names ex-BAT strategist James Yamanaka CEO, marking a strategic shift toward global growth. Find out what it means for investors today. byPallavi MadhirajuNovember 25, 2025